On behalf of Rosenblum Schwartz & Fry posted in Drug Crimes on Thursday, March 8, 2018.
Opioid addiction is a burning concern for state and federal authorities across the United States, including in Missouri. Prescription drug misuse and related problems have been termed a “crisis” by many commentators. Legislators and law enforcers seek desperately to gain control over what they view as an alarming and escalating issue.
Harsh criminal and civil penalties clearly play a central part of the strategy employed by federal regulators against the opioid epidemic. That is often well evidenced, including just last week by Attorney General Jeff Sessions in remarks delivered at a press conference.
The main thrust of the AG’s comments was that principals in large pharmaceutical enterprises will need to act in a manner the feds believe is in good faith or risk heavy sanctions. Sessions has tasked DOJ investigators with closely probing pharma firms for “false, deceptive, and unfair marketing of opioid drugs.”
When evidence establishes wrongdoing, Sessions says that prosecutors will routinely go to court in search of tough remedies aimed at compensating American taxpayers and curbing national addiction.
Our attorneys at the proven St. Louis criminal defense firm of Rosenblum Schwartz & Fry know intimately well about opioid addiction. We see daily the magnitude of the problem and the hard consequences that ensue for many criminal defendants.
Our firm strives hard to obtain fair and meaningful sentencing outcomes for our drug clients, knowing that many of them are guilty of nothing more than an addictive challenge to a drug like OxyContin or Xanax. We use our experience to aggressively defend against drug charges and secure favorable terms for individuals who are best benefited by prison-free dispositions.
It is vital that drug addiction problems be squarely faced. And it is equally important that criminal drug cases involving addiction be fairly and compassionately resolved.